Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Department of Health and Human Services
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Funding
Award size
$100K – $1M
Award ceiling
600000
Type
Grant
Dates
Deadline
Later
Posted
07/11/2025
Closes
2028-02-08
Eligibility
Eligibility
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Program
Funding area
Agriculture - AGConsumer Protection - CPFood and Nutrition - FN
Opportunity #
RFA-FD-25-017
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov